2017 Q2 Form 10-Q Financial Statement

#000117184317004086 Filed on July 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $10.22M $8.687M
YoY Change 17.69% 4.94%
Cost Of Revenue $6.774M $5.777M
YoY Change 17.25% 3.25%
Gross Profit $3.449M $2.909M
YoY Change 18.55% 8.46%
Gross Profit Margin 33.74% 33.49%
Selling, General & Admin $4.113M $3.465M
YoY Change 18.71% 10.43%
% of Gross Profit 119.27% 119.1%
Research & Development $733.7K $1.232M
YoY Change -40.45% 15.71%
% of Gross Profit 21.27% 42.34%
Depreciation & Amortization $220.0K $190.0K
YoY Change 15.79% 11.76%
% of Gross Profit 6.38% 6.53%
Operating Expenses $4.847M $4.697M
YoY Change 3.2% 3.69%
Operating Profit $1.730M $1.229M
YoY Change 40.8% 4.02%
Interest Expense $7.409K $15.47K
YoY Change -52.09% 157.58%
% of Operating Profit 0.43% 1.26%
Other Income/Expense, Net $0.00 $10.00K
YoY Change -100.0%
Pretax Income $1.730M $1.250M
YoY Change 38.4% 5.93%
Income Tax $237.8K $225.4K
% Of Pretax Income 13.75% 18.03%
Net Earnings $1.352M $917.4K
YoY Change 47.42% 1.32%
Net Earnings / Revenue 13.23% 10.56%
Basic Earnings Per Share $0.30 $0.20
Diluted Earnings Per Share $0.30 $0.20
COMMON SHARES
Basic Shares Outstanding 4.527M 4.539M
Diluted Shares Outstanding 4.592M 4.564M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.260M $6.870M
YoY Change 5.68% 8.7%
Cash & Equivalents $3.500M $4.627M
Short-Term Investments $3.760M $2.240M
Other Short-Term Assets $420.0K $910.0K
YoY Change -53.85% -31.06%
Inventory $7.880M $7.411M
Prepaid Expenses $421.7K $489.9K
Receivables $7.490M $5.290M
Other Receivables $1.600M $1.860M
Total Short-Term Assets $24.64M $22.35M
YoY Change 10.29% 7.33%
LONG-TERM ASSETS
Property, Plant & Equipment $7.452M $7.298M
YoY Change 2.11% 2.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $18.90M $18.60M
YoY Change 1.6% -13.59%
Other Assets $71.69K $199.2K
YoY Change -64.02% -82.05%
Total Long-Term Assets $21.90M $23.13M
YoY Change -5.29% -25.51%
TOTAL ASSETS
Total Short-Term Assets $24.64M $22.35M
Total Long-Term Assets $21.90M $23.13M
Total Assets $54.00M $52.77M
YoY Change 2.33% 1.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.558M $2.769M
YoY Change 28.49% 30.63%
Accrued Expenses $1.230M $1.180M
YoY Change 4.24% 5.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.791M $3.953M
YoY Change 21.19% 11.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.791M $3.953M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $7.490M $7.080M
YoY Change 5.79% -1.39%
SHAREHOLDERS EQUITY
Retained Earnings $35.69M $35.10M
YoY Change 1.69%
Common Stock $14.07M $13.83M
YoY Change 1.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $46.51M $45.69M
YoY Change
Total Liabilities & Shareholders Equity $54.00M $52.77M
YoY Change 2.33% 1.74%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $1.352M $917.4K
YoY Change 47.42% 1.32%
Depreciation, Depletion And Amortization $220.0K $190.0K
YoY Change 15.79% 11.76%
Cash From Operating Activities $3.650M $1.800M
YoY Change 102.78% -614.29%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$210.0K
YoY Change -4.76% -12.5%
Acquisitions
YoY Change
Other Investing Activities -$3.010M $500.0K
YoY Change -702.0% -50.0%
Cash From Investing Activities -$3.210M $290.0K
YoY Change -1206.9% -62.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 10.00K
YoY Change 0.0% -75.0%
NET CHANGE
Cash From Operating Activities 3.650M 1.800M
Cash From Investing Activities -3.210M 290.0K
Cash From Financing Activities 10.00K 10.00K
Net Change In Cash 450.0K 2.100M
YoY Change -78.57% 356.52%
FREE CASH FLOW
Cash From Operating Activities $3.650M $1.800M
Capital Expenditures -$200.0K -$210.0K
Free Cash Flow $3.850M $2.010M
YoY Change 91.54% -1927.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
ntic Allocated Share Based Compensation Expense Estimate Fiscal Year Two
AllocatedShareBasedCompensationExpenseEstimateFiscalYearTwo
79800
ntic Allocated Share Based Compensation Expense Estimate Next Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateNextFiscalYear
159600
ntic Allocated Share Based Compensation Expense Estimate Remainder Of Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateRemainderOfFiscalYear
97916
CY2017Q2 ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
CY2016Q2 ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
CY2017Q2 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2016Q2 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2017Q2 ntic Entity Wide Trade Joint Venture Receivables Four Joint Venturespercentage
EntityWideTradeJointVentureReceivablesFourJointVenturespercentage
0.214
CY2016Q3 ntic Entity Wide Trade Joint Venture Receivables Four Joint Venturespercentage
EntityWideTradeJointVentureReceivablesFourJointVenturespercentage
0.558
CY2017Q2 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1442048
CY2016Q2 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1351913
ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
3941667
ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
3808384
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3994102
CY2017Q2 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1224977
CY2016Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1406587
ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
-181610
ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
-97569
ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
1442714
ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
570647
ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
503863
ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
73522
CY2017Q2 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
9360883
CY2016Q2 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
7925357
ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
26552434
ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
21454381
CY2017Q2 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
862136
CY2016Q2 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
761218
ntic Net Sales To Joint Ventures
NetSalesToJointVentures
2115511
ntic Net Sales To Joint Ventures
NetSalesToJointVentures
1961565
ntic Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2017Q2 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1442048
CY2016Q2 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1351913
ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
3941667
ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
3808384
CY2017Q2 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
6190096
CY2016Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
4755320
CY2017Q2 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
1295766
CY2016Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
791903
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3558280
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2753903
CY2017Q2 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
600000
CY2016Q2 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
215000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3652208
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3152808
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3251765
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3009617
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13983754
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13798567
us-gaap Adjustment For Amortization
AdjustmentForAmortization
89274
us-gaap Adjustment For Amortization
AdjustmentForAmortization
89275
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2017Q2 us-gaap Assets
Assets
53999967
CY2016Q3 us-gaap Assets
Assets
51070050
CY2017Q2 us-gaap Assets Current
AssetsCurrent
24644578
CY2016Q3 us-gaap Assets Current
AssetsCurrent
20942171
CY2017Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
21903490
CY2016Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
22852007
CY2017Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3756680
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2243864
CY2017Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
3756680
CY2016Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2243864
CY2017Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6623104
CY2016Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6528252
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3395274
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2623981
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3500164
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4626538
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
104890
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2002557
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4527018
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4533416
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4527018
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4533416
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
90540
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
90668
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2116227
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1331507
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1794873
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
516970
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
160223
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
124840
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
353423
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
310992
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2276450
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1456347
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2148296
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
827962
CY2017Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6774001
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5777249
us-gaap Cost Of Goods Sold
CostOfGoodsSold
19256953
us-gaap Cost Of Goods Sold
CostOfGoodsSold
15920896
CY2017Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1614229
CY2016Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1639762
us-gaap Depreciation
Depreciation
580962
us-gaap Depreciation
Depreciation
482576
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<div style="display: inline; text-transform: uppercase">Recently Issued Accounting PronouncementS</div></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers, Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></div> (Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div>), which provides a framework for the recognition of revenue, with the objective that recognized revenues properly reflect amounts an entity is entitled to receive in exchange for goods and services. This guidance, which includes additional disclosure requirements regarding revenue, cash flows and obligations related to contracts with customers, was originally to be effective for the Company beginning in fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the FASB confirmed a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year deferral of the effective date of the new revenue standard which also allows early adoption as of the original effective date. The updated guidance will be effective for the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company is currently evaluating the impact of adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on its consolidated financial statements, but currently believes that the timeline established for implementation is attainable.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> &#x201c;<div style="display: inline; font-style: italic;">Inventory</div>,&#x201d; which modifies the subsequent measurement of inventories recorded under a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-in-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-out or average cost method. Under the new standard, such inventories are required to be measured at the lower of cost and net realizable value. The new standard is effective for the Company&#x2019;s fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> with prospective application. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the adoption of the provisions of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> to have a material impact on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div>&nbsp;<div style="display: inline; font-style: italic;">Income Taxes (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div>) Balance Sheet Classification of Deferred Taxes</div>,&nbsp;which requires that deferred tax assets and liabilities be classified as noncurrent in a classified balance sheet. The amendment takes effect for public entities for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> with early adoption available. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 31, 2016; </div>and there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material impact on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <!-- Field: /Page --> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;<div style="display: inline; font-style: italic;">Leases</div>.&#x201d; ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> was issued to increase transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim periods within those fiscal years, with earlier application permitted. Upon adoption, the lessee will apply the new standard retrospectively to all periods presented or retrospectively using a cumulative effect adjustment in the year of adoption. The Company is currently assessing the effect that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07,</div> &#x201c;<div style="display: inline; font-style: italic;">Investments &#x2013; Equity Method and Joint Ventures (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323</div>): Simplifying the Transition to the Equity Method of Accounting</div>.&#x201d; Among other things, the amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07</div> eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor&#x2019;s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> retroactive adjustment of the investment is required. The amendments require that an entity that has an available-for-sale equity security that becomes qualified for the equity method of accounting recognize through earnings the unrealized holding gain or loss in accumulated other comprehensive income at the date the investment becomes qualified for use of the equity method. The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016. </div>The amendments should be applied prospectively upon their effective date to increases in the level of ownership interest or degree of influence that result in the adoption of the equity method. Early adoption is permitted. The Company is currently assessing the impact that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07</div> will have on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Stock Compensation</div>, which is intended to simplify several aspects of the accounting for share-based payment award transactions. The guidance will be effective for the fiscal year beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>including interim periods within that year. The Company is currently assessing the impact that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> will have on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows, Classification of Certain Cash Receipts and Cash Payments</div>&#x201d;&nbsp;&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayments or extinguishment costs, the maturing of a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero</div> coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The guidance is effective for fiscal years beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>Early adoption is permitted. The Company is currently evaluating the effects of adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> on its consolidated financial statements, but the adoption is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a significant impact as of the filing of this report.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe any of these accounting pronouncements has had or will have a material impact on the Company&#x2019;s consolidated financial position or operating results.</div></div>
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-14144
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-27255
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
984789
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
938363
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5179786
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5449543
CY2017Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
52062465
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
52407026
CY2017Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
48064624
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
48922924
CY2017Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
13773839
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
12433700
CY2017Q2 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
38041054
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
39872543
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
32376247
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
29745795
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
8562834
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
7188274
CY2017Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
247572
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
100783
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
73098215
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
66223514
CY2017Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
18903473
CY2016Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
19840774
CY2017Q2 us-gaap Equity Method Investments
EquityMethodInvestments
18903473
CY2016Q3 us-gaap Equity Method Investments
EquityMethodInvestments
19840774
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1314103
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1278597
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1682669
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1957868
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5996977
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5939032
CY2017Q2 us-gaap Gross Profit
GrossProfit
3449018
CY2016Q2 us-gaap Gross Profit
GrossProfit
2909326
us-gaap Gross Profit
GrossProfit
9410992
us-gaap Gross Profit
GrossProfit
7495050
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1686016
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1664464
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4343159
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3600884
CY2017Q2 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1733525
CY2016Q2 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1249382
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
2867814
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1142691
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
237801
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
225395
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
480423
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
262359
CY2017Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2016Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-363514
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-24939
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
154171
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
314038
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
155011
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17185
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-19197
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
58518
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
64756
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
42872
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2017Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
375531
CY2016Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
215905
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
816845
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
692741
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3466
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-377
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-145203
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24831
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
49059
CY2017Q2 us-gaap Interest Expense
InterestExpense
7409
CY2016Q2 us-gaap Interest Expense
InterestExpense
15465
us-gaap Interest Expense
InterestExpense
15502
us-gaap Interest Expense
InterestExpense
30987
CY2017Q2 us-gaap Interest Paid
InterestPaid
7409
CY2016Q2 us-gaap Interest Paid
InterestPaid
15465
us-gaap Interest Paid
InterestPaid
15502
us-gaap Interest Paid
InterestPaid
30987
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6425328
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6258891
CY2017Q2 us-gaap Inventory Gross
InventoryGross
7879656
CY2016Q3 us-gaap Inventory Gross
InventoryGross
7711287
CY2017Q2 us-gaap Inventory Net
InventoryNet
7879656
CY2016Q3 us-gaap Inventory Net
InventoryNet
7711287
CY2017Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1454328
CY2016Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1452396
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10996
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
29868
us-gaap Investment Income Interest
InvestmentIncomeInterest
19075
us-gaap Investment Income Interest
InvestmentIncomeInterest
58425
CY2017Q2 us-gaap Land
Land
310365
CY2016Q3 us-gaap Land
Land
310365
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53999967
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51070050
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4790666
CY2017Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4170638
CY2016Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3590063
CY2017Q2 us-gaap Minority Interest
MinorityInterest
2694396
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1512816
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
212351
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
124780
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
91836
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1228685
us-gaap Operating Income Loss
OperatingIncomeLoss
2864241
us-gaap Operating Income Loss
OperatingIncomeLoss
1107998
CY2016Q3 us-gaap Minority Interest
MinorityInterest
2540973
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-308689
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-228817
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2398443
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-794668
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2826166
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3053297
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
1352416
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
917373
us-gaap Net Income Loss
NetIncomeLoss
2037021
us-gaap Net Income Loss
NetIncomeLoss
575233
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
143308
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
106614
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
350370
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
305099
CY2017Q2 us-gaap Noncurrent Assets
NoncurrentAssets
7451899
CY2016Q3 us-gaap Noncurrent Assets
NoncurrentAssets
7275872
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
4847144
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
4697018
us-gaap Operating Expenses
OperatingExpenses
14831577
us-gaap Operating Expenses
OperatingExpenses
13796320
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1729938
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
247597
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301836
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71685
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92874
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
780726
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
432360
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-239095
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-52370
CY2017Q2 us-gaap Other Income
OtherIncome
CY2016Q2 us-gaap Other Income
OtherIncome
6294
us-gaap Other Income
OtherIncome
us-gaap Other Income
OtherIncome
7255
CY2017Q2 us-gaap Other Operating Income
OtherOperatingIncome
3128064
CY2016Q2 us-gaap Other Operating Income
OtherOperatingIncome
3016377
us-gaap Other Operating Income
OtherOperatingIncome
8284826
us-gaap Other Operating Income
OtherOperatingIncome
7409268
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
196164
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
97450
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
5449543
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
760847
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
490481
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2017Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2016Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
421708
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
422031
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
5179786
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
46475
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
68633
CY2017Q2 us-gaap Profit Loss
ProfitLoss
1495724
CY2016Q2 us-gaap Profit Loss
ProfitLoss
1023987
us-gaap Profit Loss
ProfitLoss
2387391
us-gaap Profit Loss
ProfitLoss
880332
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11104107
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10428680
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7451899
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7275872
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
733651
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1231950
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2118210
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3349572
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3500164
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3395274
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35692376
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33655357
CY2017Q2 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
16829258
CY2016Q3 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
17779912
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
10223019
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
8686575
us-gaap Sales Revenue Net
SalesRevenueNet
28667945
us-gaap Sales Revenue Net
SalesRevenueNet
23415946
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q2 us-gaap Selling Expense
SellingExpense
2430824
CY2016Q2 us-gaap Selling Expense
SellingExpense
1507200
us-gaap Selling Expense
SellingExpense
6716390
us-gaap Selling Expense
SellingExpense
4507716
us-gaap Share Based Compensation
ShareBasedCompensation
293748
us-gaap Share Based Compensation
ShareBasedCompensation
325576
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.464
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.48
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
271791
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y266D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y259D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
293748
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
325576
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
14525
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
7511
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
46514905
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
44534975
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49209301
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47075948
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
13.51
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
12.98
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4591527
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4563801
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4571395
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4587064
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4526771
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4538970
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4528523
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4538005

Files In Submission

Name View Source Status
0001171843-17-004086-index-headers.html Edgar Link pending
0001171843-17-004086-index.html Edgar Link pending
0001171843-17-004086.txt Edgar Link pending
0001171843-17-004086-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_071417p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lynch_sig.jpg Edgar Link pending
ntic-20170531.xml Edgar Link completed
ntic-20170531.xsd Edgar Link pending
ntic-20170531_cal.xml Edgar Link unprocessable
ntic-20170531_def.xml Edgar Link unprocessable
ntic-20170531_lab.xml Edgar Link unprocessable
ntic-20170531_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wolsfeld_sig.jpg Edgar Link pending